Pharmaceutical Industry Labor-management Association
AI Overview
With $1.6M in lobbying spend across 26 quarterly filings, Pharmaceutical Industry Labor-management Association is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $180K |
| 2019 | $180K |
| 2020 | $180K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy
Childrens Health Insurance Program
Importation of drugs from Canada
Childrens Health Insurance Program
Importation of drugs from Canada
Medicare Part D - Rebates
HR. 1344 Competitive DRUGS Act of 2019
HR. 1344 Competitive DRUGS Act of 2019
Drug importation from Canada
Drug importation from Canada
HR 3 Lower Drug Costs Now Act of 2019
H.R. 3 Lower Drug Prices- Cummings Act
Drug importation from Canada
ACA Stabilization - Drug Pricing
Drug importation from Canada
Drug Price controls
Drug importation from Canada
Showing 8 of 15 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.